Hybrid breast augmentation combines a silicone implant with autologous fat grafting, but one point often overlooked in real practice is how to address hybrid breast augmentation asymmetry. Every natural breast has some degree of side-to-side difference, and simply placing identical implants on both sides can accentuate that imbalance instead of correcting it. In a recent case in a woman in her 30s, we placed a Motiva Mini 200cc implant on each side in the subglandular plane, and deliberately varied the fat grafting volume between sides using a “split injection” strategy. This article walks through the design logic and the differing roles of subcutaneous versus subglandular fat injection.

Key Points of This Article

・Hybrid breast augmentation asymmetry does not resolve simply by placing the same-size implants; a split design based on preoperative measurement is essential.
・Subcutaneous fat injection smooths the outer contour, while subglandular injection adds volume between the gland and pectoralis muscle.
・Small implants such as the Motiva Mini 200cc suit thin chest walls, providing a natural “foundation” to layer fat over.
・Fat centrifugation should be low-speed and short-duration to protect adipocyte viability and support long-term take.
・Perfect symmetry is not achievable, but meaningful visual symmetry is a realistic goal.

Why Hybrid Breast Augmentation Asymmetry Occurs

Even in healthy adult women, one breast being 20–30 ml larger than the other is common. Rib cage asymmetry, glandular mass differences and subcutaneous fat distribution combine to create this baseline imbalance, and we quantify it preoperatively with palpation, ultrasound and upright marking measurements. The design of a hybrid procedure builds an intentionally asymmetric plan for implant choice and fat volumes based on this assessment. Identical implants can either shrink the visible gap if the smaller side gains proportionally more fullness, or magnify it if skin elasticity or subglandular space is unequal. A split design guided by measurement is therefore indispensable.

What We Measure Preoperatively

We quantify nipple-areolar position, the inframammary fold (IMF) line, presence of pectus deformity, subcutaneous fat thickness by pinch test, and skin elasticity on each side. From this we decide whether to keep implants symmetric while balancing volumes with fat, or to vary the implants themselves. Our default is to keep implants identical because unequal implants raise the risk of rotation and capsular contracture; we prefer to fine-tune with fat grafting.

Why We Chose the Motiva Mini 200cc

Small implants make sense as a “natural foundation” in slim patients with thin overlying tissue. Large implants tend to show their outline, producing rippling and an upper-pole step. A 200cc-range mini implant conforms to the rib cage more easily and integrates better with grafted fat placed above it. When the goal is proportional upper-body harmony rather than sheer size — as in this case — the Motiva surface characteristics and modest 200cc volume fit the bill. Correcting hybrid breast augmentation asymmetry is also easier with a small implant plus fat, because fat can be steered volumetrically in ways a larger implant cannot.

The Rationale Behind 80ml Subcutaneous + 20ml Subglandular Split Grafting

Fat can be placed in the subcutaneous plane, the subglandular plane, or within the pectoralis muscle. Subcutaneous grafting smooths the décolletage and lateral contour; subglandular grafting thickens the space between the gland and the pectoralis to fill in the upper pole of the implant. In this case we injected about 80 ml of fat subcutaneously on each side and added a small subglandular graft on only one side. That reflected an asymmetry we identified preoperatively in subglandular fullness — even a small volume placed in the anatomically correct plane restores visual symmetry. Splitting the graft into thin, wide layers also reduces the risk of nodules and oil cysts from local over-injection.

Case Details: Procedure, Cost and Risks

【Procedure】This is a representative case of hybrid breast augmentation in a woman in her 30s. Motiva Mini 200cc implants were placed bilaterally in the subglandular plane. Fat was harvested from the inner and anterior thighs and from the upper arms and shoulders, then split-injected into both breasts subcutaneously with an additional subglandular graft on one side only. Implants were placed via an axillary incision, with small additional entry points at the elbow, groin, and inframammary area for harvesting and grafting.

【Cost】For hybrid breast augmentation and liposuction fees, please check our pricing page. The total varies with the liposuction sites, implant type, and graft volume.

【Main Risks and Side Effects】Implant-related risks include capsular contracture, implant rotation, rupture, hematoma and infection. Fat-graft-related risks include palpable nodules, oil cysts, calcification, variable take rate, and residual asymmetry. Donor site risks include bruising, swelling, fibrosis, contour irregularity, pigmentation, and transient numbness. Individual results vary and photographs represent one case. For general cosmetic surgery safety standards, refer to the Japan Society of Aesthetic Surgery.

Intraoperative Fat Handling and Graft Survival

Processing conditions applied to harvested fat directly affect take rate. In this case we used low-speed, short-duration centrifugation to separate saline, tumescent fluid and blood while preserving adipocyte viability. Aggressive high-speed spins reduce extracellular fluid — which improves apparent injection efficiency — but the mechanical shear can rupture the adipocytes themselves and depress take rate. Fine-tuning hybrid breast augmentation asymmetry depends not only on volume design but also on protecting the biological quality of the injected fat.

Recovery Timeline and Downtime

Immediately after surgery the breast feels tighter than the final result because of the implant volume plus edema and small hematoma. Swelling starts to subside over 2–4 weeks, and fat resorption and take proceed in parallel. Final volume and shape stabilize at 3–6 months. Donor-site (thigh and upper arm) fibrosis peaks between weeks 3 and 8, and compression garment use, appropriate lymphatic care and nutrition drive recovery speed. Sharp weight fluctuation during recovery affects graft take, so a stable routine is recommended through the first 3 postoperative months.

Frequently Asked Questions

Q. Can hybrid breast augmentation correct pre-existing breast asymmetry?

Yes — the realistic plan is to keep implants the same size while asymmetric fat grafting corrects visual symmetry, guided by objective preoperative measurement. Perfect symmetry is not achievable, but reducing the difference to a level not noticeable from front or oblique views is realistic.

Q. What is the benefit of choosing a small implant like the Motiva Mini?

Slim patients with a prominent chest wall tend to reveal the outline of large implants, causing rippling and an upper-pole step. Using a small implant as a foundation and layering fat over it delivers both a natural look and better reproducibility.

Q. Why inject fat into both the subcutaneous and subglandular planes?

The two planes serve different roles: the subcutaneous plane smooths the contour, while the subglandular plane adds volume between gland and muscle. Splitting the graft into thin, wide layers avoids local over-injection, which is a driver of graft failure and nodule formation.

Q. Where is the fat for asymmetry correction harvested from?

The lower body offers stable quality and quantity, so inner/anterior thighs and lower abdomen are usually first choice. Fat can also be co-harvested from the upper arms — efficiency is lower because of higher fibrous content, but the aesthetic benefit of a slimmer upper arm is often welcome.

Q. Will the two sides be perfectly symmetric after surgery?

No — skeletal-level asymmetry persists, so perfect symmetry is not a realistic goal. Meaningful visual improvement is achievable, and that outcome depends on preoperative measurement, a well-planned split-injection design, and postoperative graft-take management.

For related articles on hybrid breast augmentation and fat grafting, please visit our liposuction and breast augmentation column archive.

──────────────
【Supervising Physician】Shin Moriwaki, M.D.
Member of Japan Society of Aesthetic Surgery (JSAS) / Member of American Academy of Aesthetic Medicine
ECFMG Certificate (US Medical License Qualification)
──────────────

📍AVAN TOKYO GINZA LIPOSUCTION CLINIC
English / 中文 / Tiếng Việt supported
Bookings and consultations available via
DM / LINE / Website / Phone.